Lisa Vermij

9PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 07, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-Low.

Dione van Dijk, Lisa Vermij, Alicia León-Castillo

|Sep 29, 2023
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.

Amy Jamieson, Lisa Vermij, Claire J H Kramer

|May 25, 2023
QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction.

Anne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij

|Jan 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.

Lisa Vermij, Jan J Jobsen, Alicia León-Castillo

|Jun 25, 2022
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.

Lisa Vermij, Alicia Léon-Castillo, Naveena Singh

|Apr 09, 2021
Performance of a HER2 testing algorithm specific for p53-abnormal endometrial cancer.

Lisa Vermij, Naveena Singh, Alicia Leon-Castillo

Pageof 2

Frequent Collaborators

6 joint publications

Carien L Creutzberg

5 joint publications

Nanda Horeweg

4 joint publications

Emma J Crosbie

4 joint publications

Tjalling Bosse